Podcast Episodes
Back to Search
Inside the Issue: Integrating HER2-Targeted Strategies into the Management of Gastrointestinal Cancers
Season 1
Dr Tanios Bekaii-Saab from the Mayo Clinic Cancer Center in Phoenix, Arizona, and Dr John Strickler from Duke University in Durham, North Ca…
1 year, 5 months ago
Optimizing the Management of Dedifferentiated Liposarcoma
Season 1
Dr Mrinal Gounder from Memorial Sloan Kettering Cancer Center in New York, New York, discusses recent updates on available and emerging trea…
1 year, 5 months ago
Inside the Issue: Integrating Antibody-Drug Conjugates into the Management of HR-Positive and Triple-Negative Metastatic Breast Cancer
Season 1
Prof Peter Schmid from the Barts Cancer Institute in London, United Kingdom, and Dr Sara Tolaney from the Dana-Farber Cancer Institute in Bo…
1 year, 6 months ago
Current and Future Management of Non-Small Cell Lung Cancer with an EGFR Mutation
Season 1
Dr Pasi Jänne from the Dana-Farber Cancer Institute in Boston, Massachusetts, Prof Tom John from the Peter MacCallum Cancer Centre in Melbou…
1 year, 6 months ago
Management of Metastatic Urothelial Bladder Cancer
Season 1
Dr Michiel van der Heijden from the Netherlands Cancer Institute in Amsterdam discusses the management of metastatic urothelial bladder canc…
1 year, 6 months ago
Special Edition — Key Presentations on Breast Cancer from the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting
Season 1
Dr Priyanka Sharma from The University of Kansas Cancer Center in Westwood, Kansas, discusses recent advances in the treatment of breast can…
1 year, 6 months ago
An interview with Professor Giuseppe Curigliano, MD, PhD — Management of Metastatic Breast Cancer
Season 1
Prof Giuseppe Curigliano from the European Institute of Oncology in Milano, Italy discusses current questions and controversies in the manag…
1 year, 6 months ago
An interview with Angeles Alvarez Secord, MD, MHSc — Management of Ovarian and Endometrial Cancer
Season 1
Dr Angeles Alvarez Secord from the Duke Cancer Institute in Durham, North Carolina, provides her perspectives on recent datasets from ASCO 2…
1 year, 6 months ago
Inside the Issue: Integrating ALK-Targeted Therapy into the Management of Localized Non-Small Cell Lung Cancer
Season 1
Prof Solange Peters from the Lausanne University Hospital in Lausanne, Switzerland, and Professor Ben Solomon from the Peter MacCallum Cance…
1 year, 6 months ago
Integrating Antibody-Drug Conjugates into the Management of HR-Positive and Triple-Negative Metastatic Breast Cancer
Season 1
Dr Sara A Hurvitz from the Fred Hutchinson Cancer Center in Seattle, Washington, summarizes recent trials investigating the integration of a…
1 year, 6 months ago